Breaking News

INC Research Names General Medicine EVP

July 3, 2013

Braithwaite brings 25 years of experience

Ian M. Braithwaite, Ph.D., has been appointed executive vice president and general manager of General Medicine at INC Research. Dr. Braithwaite will provide global leadership for the company’s General Medicine business unit, which specializes in conducting trials in areas ranging from infectious disease, respiratory disease, women’s health, immunology and inflammation, gastrointestinal disease and ophthalmology. Dr. Braithwaite will be based out of INC’s Camberley, UK, office.
Dr. Braithwaite brings 25 years of experience in the CRO and biopharmaceutical industries with particular expertise in immuno-inflammatory diseases. He joins the company from PPD, where he served as global therapeutic area head, General Medicine. Under his leadership, this unit experienced significant growth in revenue and backlog, boosted staff utilization and reduced turnover. Dr. Braithwaite previously served in other senior positions at PPD, including executive director and therapeutic head for Europe, Middle East and Africa, and executive director, project management performance.
“We are excited to add an experienced leader like Dr. Braithwaite to our therapeutic leadership team,” said Jamie Macdonald, INC’s chief executive officer. “Ian’s deep therapeutic experience both in the CRO and biopharmaceutical space provides a unique perspective on the efficient management of clinical development programs. As a CRO structured around a strong therapeutic focus, world-class leadership in our business units is critical to our success. Ian is responsible for significantly growing our presence in this important fast-growing market segment.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.